Brief: Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million
27/11/2024 23:21
Nov 27 (Reuters) - Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO
$300
MILLION – SEC FILING
* MARKER THERAPEUTICS : SALES AGREEMENT PROSPECTUS COVERS
OFFERING
OF UP TO $11.4 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM
TIME TO TIME
Source text: ID:n0001104659-24-123679
Further company coverage: MRKR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79